Skip to main content

Table 2 Risk of Hospital referral of “P” group, cases for whom PPCc was contacted by phone

From: Acute toxic exposures in children: analysis of a three year registry managed by a Pediatric poison control Center in Italy

Hospital Referral Yes Total Univariable analysis Multivariable logistic regression
n. (%) n. OR 95%CI OR 95%CI
Sex
 Male 160 (19.3) 829 1.1 0.9–1.4   
 Female 138 (17.6) 782 1.0    
Total 298 (18.5) 1611     
Age category
 Infant 31 (13.1) 237 1.0    
 Pre School 234 (19.6) 1193 1.6* 1.1–2.4   
 School 22 (15.8) 139 1.2 0.7–2.3   
 Adolescent 11 (26.2) 42 2.4* 1.1–5.2   
Total 298 (18.5) 1611     
Time of exposure
 Morning 64 (17.3) 371 1.0   1.0  
 Afternoon 123 (21.4) 575 1.3 0.9–1.8 1.5* 1.0–2.2
 Evening 104 (16.6) 628 1.0 0.7–1.3 1.3 0.9–1.9
 Night 7 (18.9) 37 1.1 0.5–2.7 1.2 0.5–3.3
Total 298 (18.5) 1611     
Location of poison exposure
 Outside 30 (42.3) 71 3.5* 2.1–5.7 3.9* 2.1–7.2
 Home 268 (17.4) 1539 1.0   1.0  
Total 298 (18.5) 1611     
Reasons for poison exposure
Intentional exposure 7 (58) 12     
  Abuse 1 (100) 1     
  Suicide 6 (54.5) 11 11.0* 2.7–44.4   
Accidental exposure 291 (18) 1599     
General accidental exposure 276 (19) 1452 2.1 1.2–3.8   
  Medication error 14 (9.9) 142 1.0    
  Adverse reaction 1 (20) 5 2.3 0.2–22.2   
Total 298 (18.5) 1611     
Substance
 Caustic 41 (50) 82 8.9* 3.3–23.9 44.8* 9.9–202.2
 Substance of abuse 12 (44.4) 27 7.1* 2.2–23.2 22.0* 4.3–112.6
 Other 16 (39.0) 41 5.7* 1.9–16.6 23.1* 4.6–114.8
 Plant 25 (32.1) 78 4.2* 1.6–10.8 9.5* 2.1–44.1
 Domestic product 37 (15.5) 238 1.6 0.7–3.9 8.0* 1.8–34.9
 Industrial product 38 (10.5) 363 1.0 0.4–2.4 4.2 1.0–18.2
 Pesticide 7 (10.1) 69 1.0   4.2 0.8–21.8
 Cosmetic 12 (10.5) 114 1.0 0.4–2.8 4.3 0.9–20.4
 Food 8 (12.7) 63 1.3 0.4–3.8 3.4* 0.7–17.3
 Drug 102 (19) 536 2.1 0.9–4.7 1.0  
Total 298 (18.5) 1611     
Pharmaceutical
 Cardioactive 23 (53.59 43 29.9* 4.6–194.0 26.7* 5.6–128.0
 Antistaminic 12 (42.9) 28 19.5* 3.1–123.9 17.4* 3.4–89.1
 Neuroactive 18 (40) 45 17.3* 3.1–97.3 15.4* 3.2–73.4
 Supplements 4 (16.7) 24 5.2 0.8–32.5 6.1* 1.0–37.2
 Analgesic 20 (17.2) 116 5.4* 1.2–24.9 5.8* 1.3–26.4
 None 196 (18.2) 1075 5.8* 1.4–24.1   
 Homeopathic 2 (15.4) 13 4.7 0.6–39.4 5.8 0.7–46.4
 Hormones 9 (13.8) 65 4.2 0.8–20.9 4.3 0.8–20.1
 Other 2 (9.1) 22 2.6 0.3–20.2 3.4 0.4–26.7
 Gastrointestinal 3 (13.6) 22 4.1 0.6–27.7 3.3 0.5–22.5
 Topic 4 (7.4) 54 2.1 0.4–12.0 3.2 0.5–18.3
 Respiratory 3 (6) 50 1.7 0.3–10.5 1.8 0.3–11.3
 Antibiotic 2 (3.7) 54 1.0   1.0  
Total 298 (18.5) 1611     
Route of exposition
 Ingestion 271 (21.6) 1254 5.3* 2.7–10.2 5.8* 2.9–11.6
 Eye 2 (8) 25 1.7 0.3–8.1 2.8 0.4–22.7
 Other 2 (8.3) 24 1.7 0.4–8.5 2.4 0.5–12.7
 Inhalation 4 (12.9) 31 2.8 0.8–9.8 2.7 0.7–10.7
 Skin 8 (12.5) 64 2.7 1.0–7.3 1.5 0.5–4.7
 Mucosa 10 (5) 201 1.0   1.0  
 Injection 0 (0) 2 0.0    
 Bite 0 (0) 6 0.0    
 Missing 1 (25) 4 6.4 0.6–68.4 11.5 0.9–151.9
Total 298 (18.5) 1611 1.7    
Clinical presentation
 Gastrointestinal Symptoms 58 (61.7) 94 3.7* 1.7–8.4   
 Neurologic Symptom 9 (56.3) 16 3.0 0.9–10.1   
 Respiratory Symptom 2 (100) 2   0.0   
 Others 2 (40) 5 1.5 0.2–10.6   
 Dermatological Symptoms 13 (30.2) 43 1.0    
 Multiple Symptoms 0 (0) 1 0.0    
Total 84 (52.2) 161     
Decontamination
 Charcoal 36 (59) 61 18.0* 3.1–103.8 10.0* 1.2–83.3
 None 257 (17.1) 1501 2.6 0.6–11.0 2.1 0.3–16.0
 Topic wash 2 (7.4) 27 1.0   1.9 0.2–23.7
 Ocular irrigation 2 (9.5) 21 1.3 0.2–10.5 1.0  
 Gastric lavage 1 (100) 1     
Total 298 (18.5) 1611     
  1. OR with* are those with p-value < 0.05